Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 7/20 | 0.37 |
| ▸ | PORCN | Q9H237 | 4/20 | 0.36 |
| ▸ | TACR3 | P29371 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | AKT2 | P31751 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 2/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12095518 | 0.95 | AKT1 (0.34) | AKT1PORCNTACR3CYP2D6AKT2 | |
| SCHEMBL14118948 | 0.91 | AKT1 (0.41) | AKT1PORCNAKT2PDE2A | |
| SCHEMBL14118957 | 0.88 | TACR3 (0.41) | AKT1TACR3PDE2A | |
| SCHEMBL1907030 | 0.87 | CHEK1 (0.36) | AKT1TACR3AKT2PDE2AALOX5AP | |
| SCHEMBL1903041 | 0.86 | AKT1 (0.38) | AKT1TACR3PDE2A | |
| SCHEMBL1900984 | 0.86 | AKT1 (0.40) | AKT1TACR3AKT2ABL1PDE2A | |
| SCHEMBL14119198 | 0.85 | AKT1 (0.33) | AKT1TACR3 | |
| SCHEMBL1906672 | 0.85 | TACR3 (0.38) | AKT1TACR3PDE2A | |
| SCHEMBL1900154 | 0.84 | AKT1 (0.46) | AKT1AKT2 | |
| SCHEMBL14118904 | 0.84 | TACR3 (0.37) | AKT1TACR3PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011055115-A1 | AKT / PKB INHIBITORS | ALMAC DISCOVERY LIMITED (GB) | 2011-05-12 | — | — | WO | disclosed |